| Journal | Archives of physical medicine and rehabilitation |
| Study Type | Clinical Study |
| Population | Human participants |
Multiple sclerosis patients frequently use psychoactive substances to manage symptoms, but the temporal relationships between symptom fluctuations and substance use patterns remain poorly understood. This ecological momentary assessment study provides real-world data on how MS symptoms directly influence daily substance use decisions.
This longitudinal study used smartphone-based ecological momentary assessment to track 258 ambulatory adults with MS four times daily over 14 days at baseline, 1-year, and 2-year follow-ups. Researchers examined bidirectional temporal associations between momentary symptoms (fatigue, pain, stress, depression) and use of alcohol, caffeine, nicotine, cannabis, and opioids using mixed-effects regression models. Key findings showed that momentary stress increases predicted reduced alcohol use, while higher average pain was associated with decreased alcohol consumption and increased opioid use. The study’s strength lies in its real-time data collection minimizing recall bias, though the brief 14-day assessment periods may not capture longer-term patterns.
“This study confirms what I observe clinically – MS patients aren’t simply self-medicating in predictable ways, and the relationship between symptoms and substance use is more nuanced than we often assume. The finding that stress actually decreased alcohol use challenges common assumptions about self-medication patterns.”
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
FAQ
How does cannabis use relate to symptom management in MS patients?
This study found that higher average pain levels were associated with increased cannabis use in people with MS. The real-time ecological momentary assessment data suggests patients may be self-medicating with cannabis for pain management, though the study design cannot establish causation.
Does alcohol consumption help or worsen MS symptoms?
The research indicates that momentary increases in stress actually predicted lower odds of alcohol use, and higher average pain was linked to reduced alcohol consumption. This suggests MS patients may be appropriately avoiding alcohol during symptomatic periods rather than using it for symptom relief.
What psychoactive substances do MS patients commonly use for symptom management?
The study tracked five psychoactive substances: alcohol, caffeine, nicotine, cannabis, and opioids. Cannabis and opioids showed the strongest associations with pain levels, suggesting these may be the primary substances used for symptom management in this population.
How reliable is real-time symptom tracking compared to traditional clinical assessments?
Ecological momentary assessment (EMA) provides more accurate data by capturing symptoms and substance use as they occur, rather than relying on recall during clinical visits. This study used smartphone-based EMA four times daily for 14 days across multiple time points, providing robust real-world evidence of symptom-substance use patterns.
Should clinicians be concerned about substance use patterns in MS patients?
The study reveals that MS patients appear to use substances strategically in response to symptoms rather than recreationally. Clinicians should engage in open discussions about substance use patterns, particularly cannabis and opioids for pain management, to ensure safe and effective symptom control strategies.
